Intravenous Immunoglobulin Market Size, Share, and Growth 2022-2028
Intravenous Immunoglobulin Market: Strategic Insights
Intravenous Immunoglobulin Market
-
CAGR (2021 - 2028)7.6% -
Market Size 2021
US$ 11.21 Billion -
Market Size 2028
US$ 18.67 Billion
Market Dynamics
GROWTH DRIVERS
- Increase in immunodeficiency disorders
- Growing demand for intravenous immunoglobulin therapies
FUTURE TRENDS
- Advances in immunoglobulin replacement therapies
- Increasing adoption of subcutaneous immunoglobulin treatments
OPPORTUNITIES
- Expansion in immunotherapy market
- Growth in personalized intravenous immunoglobulin therapies
Key Players
- Takeda Pharmaceutical Company Limited
- Grifols S A
- Pfizer Inc
- ADMA Biologics Inc
- Bio Products Laboratory Ltd
- Shanghai RAAS
- Octapharma AG
- Kedrion S p A
- CSL Behring CSL Limited
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type - IgG
- IgM
- IgA
- IgE
- IgD
Application - Hypogammaglobulinemia
- Chronic Inflammatory Demyelinating Polyneuropathy
- Immunodeficiency Diseases
- Myasthenia Gravis
- Multifocal Motor Neuropathy
- Idiopathic Thrombocytopenic Purpura
- Inflammatory Myopathies
- Specific Antibody Deficiency
- Guillain-Barre syndrome
Distribution Channel - Hospital Pharmacy
- Retail Pharmacy
End User - Hospitals
- Specialty Clinics
Get Free Sample For